Cardio‐Oncologic Considerations in Heart Failure With Mildly Reduced Ejection Fraction: Prevalence and Prognostic Impact of Malignancies
Journal of the American Heart Association · 2026
DOI: 10.1161/jaha.125.047798 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Tobias Schupp und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care Medical Faculty Mannheim, University Medical Centre Mannheim, Heidelb…. Hauptthemen laut MEDLINE: Heart Failure, Stroke Volume, Neoplasms, Ventricular Function, Left. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Background
Patients with malignancies were commonly excluded from prior heart failure (HF) trials resulting in limited data regarding the outcomes of patients with HF accompanied by concomitant malignancies. The study sought to assess the prevalence and prognostic impact of malignancies in patients with HF and HF with mildly reduced ejection fraction.
Methods
Consecutive patients hospitalized with HF with mildly reduced ejection fraction were retrospectively included at 1 institution from 2016 to 2022. The prognosis of patients with malignancies was investigated regarding the primary end point all‐cause mortality at 30 months (median follow‐up). The key secondary end point was rehospitalization for worsening HF.
Results
Among 2184 patients with HF with mildly reduced ejection fraction, 15.3% (n=335) suffered from concomitant malignancies. In patients with active malignancies (n=257), most patients had solid (n=175) followed by hematological malignancies (n=73) (both: n=9), whereas cancer‐therapy HF was observed in 3.9%. Patients with malignancies had lower rates of ischemic cardiomyopathy and were less commonly treated with beta blockers, renin‐angiotensin aldosterone antagonists, and statins. The presence of malignancies was associated with a higher risk of long‐term all‐cause mortality (59.4% versus 26.2%; P =0.001; adjusted hazard ratio, 2.568 [95% CI, 2.101–3.138]; P =0.001), which was already observed during index hospitalization (8.4% versus 2.5%; P =0.001) and mainly attributed to noncardiac mortality. In contrast, the risk of HF‐related rehospitalization did not significantly differ in both groups.
Conclusions
Malignancies were present in 15% of patients with HF with mildly reduced ejection fraction and independently associated with long‐term all‐cause mortality, mainly attributed to an increased risk of in‐hospital noncardiac mortality. The risk of HF‐related rehospitalization was not affected by the presence of concomitant malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care Medical Faculty Mannheim, University Medical Centre Mannheim, Heidelberg University Heidelberg Germany.
- Department of Cardiology, Angiology and Pneumology University Hospital Heidelberg Heidelberg Germany.
- Department of Hematology and Oncology University Hospital Mannheim, Heidelberg University Mannheim Germany.
ORCID-Profile: Tobias Schupp, Mohammad Abumayyaleh, Kathrin Weidner, Felix Lau, Marielen Reinhardt, Noah Abel, Jonas Rusnak, Daniel Duerschmied, Ibrahim Akin, Michael Behnes
Zitieren
APA
Schupp, T., Goertz, M., Dudda, J., Abumayyaleh, M., Weidner, K., Schmitt, A., Lau, F., Reinhardt, M., Abel, N., Rusnak, J., Lübke, J., Duerschmied, D., Akin, I., & Behnes, M. (2026). Cardio‐Oncologic Considerations in Heart Failure With Mildly Reduced Ejection Fraction: Prevalence and Prognostic Impact of Malignancies. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.047798
Vancouver
Schupp T, Goertz M, Dudda J, Abumayyaleh M, Weidner K, Schmitt A, et al. Cardio‐Oncologic Considerations in Heart Failure With Mildly Reduced Ejection Fraction: Prevalence and Prognostic Impact of Malignancies. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.047798
BibTeX
@article{Schupp2026,
author = {Schupp, Tobias and Goertz, Michelle and Dudda, Jonas and Abumayyaleh, Mohammad and Weidner, Kathrin and Schmitt, Alexander and Lau, Felix and Reinhardt, Marielen and Abel, Noah and Rusnak, Jonas and Lübke, Johannes and Duerschmied, Daniel and Akin, Ibrahim and Behnes, Michael},
title = {Cardio‐Oncologic Considerations in Heart Failure With Mildly Reduced Ejection Fraction: Prevalence and Prognostic Impact of Malignancies},
journal = {Journal of the American Heart Association},
year = {2026},
doi = {10.1161/jaha.125.047798}
}
EUVIMED